國家衛生研究院 NHRI:Item 3990099045/8205
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 966868      線上人數 : 727
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8205


    題名: Overexpression of DPP4 is a poor prognostic factor for patients with urothelial carcinoma of the upper urinary tract and urinary bladder
    作者: Liang, PI;Wu, WJ;Huang, CN;Li, CC;Ke, HL;Li, WM;Yeh, HC;Li, CF;Lee, YY;Lin, HH;Yeh, BW;Hwang, SJ
    貢獻者: National Institute of Cancer Research
    摘要: Background：Dipeptidyl peptidase-4 (DPP4), also known as CD26, is an enzyme that cleaves a diversity of protein that contains proline or analine, including chemokines, growth factors, and neuropeptide. Different DPP4 expression status has been observed in malignant tumours, including colon, renal, and ovarian carcinoma. Data mining of the published dataset (GSE31684) identified that DPP4 is significantly upregulated in urothelial carcinoma of the urinary bladder. We therefore analysed the association of DPP4 expression and outcome in our well-characterised cohort of urothelial carcinoma. Methods: Laser capture microdissection coupled with real-time qRT-PCR was used to evaluate DPP4 transcript level in 20 urothelial carcinomas of the urinary bladder. DPP4 immunostaining was done on 340 cases of urothelial carcinoma of the upper urinary tract and 295 cases of urothelial carcinoma of the urinary bladder. The expression status of DPP4 was then correlated with various clincopathological factors, disease-specific survival (DSS), and metastasis-free survival (MeFS). Findings: DPP4 mRNA expression was significantly increased in urothelial carcinomas with higher pT status (p < 0.001). In both groups of urothelial carcinomas, increment of DPP4 immunoexpression was significantly associated with advanced pT stage (both p < 0.001), high histological grade (urothelial carcinoma of the upper urinary tract, p = 0.019), lymph node metastasis (urothelial carcinoma of the upper urinary tract,p < 0.001; urothelial carcinoma of the urinary bladder, p = 0.033), vascular invasion (both p < 0.001), perineurial invasion (urothelial carcinoma of the urinary bladder, p = 0.021) and frequent mitosis (urothelial carcinoma of the upper urinary tract, p = 0.003). DPP4 overexpression independently predicted poor DSS (urothelial carcinoma of the upper urinary tract, p = 0.028; urothelial carcinoma of the urinary bladder,p < 0.0001) and MeFS (urothelial carcinoma of the upper urinary tract, p = 0.031; urothelial carcinoma of the urinary bladder, p < 0.0001) in both groups of patients. Interpretation: Our study shows that overexpression of DPP4 is significantly associated with aggressive tumour behaviour and poor outcome. DPP4 may have an important role in tumorigenesis of urothelial carcinoma.
    日期: 2014-05
    關聯: European Journal of Cancer. 2014 May;50(Suppl. 4):e39.
    Link to: http://dx.doi.org/10.1016/j.ejca.2014.03.152
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351589200110
    顯示於類別:[其他] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SDO0959804914004249.pdf35KbAdobe PDF518檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋